Evidence map›Paper›PMID 29221349›Full record

ArticleJournal of thoracic disease2017

AB thymoma with atypical type A component with delayed multiple lung and brain metastases.

Wieslawa Grajkowska, Ewa Matyja, Jacek Kunicki, Sylwia Szymanska, Alexander Marx, Cleo-Aron Weis, Renata Langfort, Malgorzata Szolkowska

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Journal of thoracic disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Differences and similarities ofTranslational lung cancer research · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Wieslawa GrajkowskaDepartment of Pathology, The Children's Memorial Health Institute, Warsaw, Poland.
Ewa MatyjaDepartment of Experimental and Clinical Neuropathology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Jacek KunickiDepartment of Neurosurgery, M. Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland.
Sylwia SzymanskaDepartment of Pathology, The Children's Memorial Health Institute, Warsaw, Poland.
Alexander MarxInstitute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Cleo-Aron WeisInstitute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
Renata LangfortDepartment of Pathology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
Malgorzata SzolkowskaDepartment of Pathology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland.
Children's Memorial Health Institute · PLHeidelberg University · DEPolish Academy of Sciences · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PLUniversity Medical Centre Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An atypical type A thymoma is a newly added entity to the last World Health Organization (WHO) histological classification [2015] of uncertain prognosis. The conventional type A and AB thymomas are usually locally aggressive neoplasms that rarely metastasize with distant metastases to the central nervous system (CNS) occurring extremely exceptionally. We present a history of a woman with a mediastinal tumor originally considered to be a Masaoka-Koga stage II "mixed thymoma with well-differentiated thymic carcinoma component" according to the historic Müller-Hermelink nomenclature. By applying the criteria of the new WHO classification the tumor should be reclassified as an AB thymoma with an atypical A component. The patient developed metastases to the lung and brain 10 and 15 years after the original diagnosis, respectively. All metastases morphologically corresponded to an atypical A component of primary thymoma. Molecular study revealed

Indexed as

atypical type AB thymomabrain metastasesGTF2I mutationlung metastasesThymoma

Identifiers

PMID29221349
PMCPMC5708497
OpenAlexW2751680056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.